| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 06/27/2013 | WO2013094339A1 METHOD FOR PRODUCING HIGH-QUALITY ε-CAPROLACTAM |
| 06/27/2013 | WO2013093842A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 06/27/2013 | WO2013093333A1 Novel process for synthesizing ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 06/27/2013 | WO2013093220A1 Method for synthesising ivabradine and the pharmaceutically acceptable acid addition salts thereof |
| 06/27/2013 | US20130165649 Ruthenium complexes for use in olefin metathesis |
| 06/27/2013 | US20130165648 Processes for preparing 3-benzazepines |
| 06/27/2013 | CA2858328A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 06/26/2013 | EP2607354A1 Process for the synthesis of ivabradine and addition salts thereof and its pharmaceutically acceptable acid |
| 06/26/2013 | EP2607353A1 New method for synthesising ivabradine and its added salts with a pharmaceutically acceptable acid. |
| 06/26/2013 | EP2605767A1 Ship1 modulators and related methods |
| 06/26/2013 | CN103172567A Process for the synthesis of ivabradine and addition salts thereof and its pharmaceutically acceptable acid |
| 06/26/2013 | CN103172566A New method for synthesising ivabradine and its added salts with a pharmaceutically acceptable acid |
| 06/26/2013 | CN103172565A Resolution method of chiral fenoldpam |
| 06/25/2013 | US8470850 Inhibitors of VEGF receptor and HGF receptor signalling |
| 06/20/2013 | US20130158257 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 06/20/2013 | US20130158229 Processes for the production of hydrogenated products and derivatives thereof |
| 06/20/2013 | US20130158013 Processes for the preparation of 5-ht2c receptor agonists |
| 06/20/2013 | US20130157339 Stabilized protease composition |
| 06/20/2013 | CA2798633A1 Novel synthesis process for ivabradine and its addition salts to a pharmaceutically acceptable acid |
| 06/20/2013 | CA2795741A1 Novel synthesis process for ivabradine and its addition salts to a pharmaceutically acceptable acid |
| 06/19/2013 | CN103159641A Method for preparing intermediate 2-carboxylic acid-5-(2-methyl-benzoylamino)toluene for tolvaptan |
| 06/19/2013 | CN102304088B Ivabradine compound, preparation method and pharmaceutical composition thereof |
| 06/18/2013 | US8466143 Azepine derivatives as pharmaceutical agents |
| 06/18/2013 | US8466142 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 06/13/2013 | US20130150551 Processes for the production of hydrogenated products and derivatives thereof |
| 06/12/2013 | EP2601840A2 Chemical and biological agents for the control of molluscs |
| 06/12/2013 | CN103145619A Preparation method of 7-chloro-6-benzenesulfonamido-2,3,4,5-tetrahydro-1H-benzo[d]nitrogen heterocyclic |
| 06/12/2013 | CN103145618A Method for cogeneration of caprolactam and ammonium sulfate |
| 06/12/2013 | CN101671291B Organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/12/2013 | CN101573333B Inhibitors of histone deacetylase |
| 06/11/2013 | US8460704 Extended release formulation of nevirapine |
| 06/06/2013 | WO2013080615A1 Reaction device |
| 06/05/2013 | CN103130717A Preparation method of 2-benzo diazepine anthrone |
| 06/05/2013 | CN103130237A Method for producing zeolite molded article and method for producing epsilon-caprolactam |
| 06/04/2013 | US8455646 Alkaloid aminoester derivatives and medicinal composition thereof |
| 05/30/2013 | WO2013078244A1 Carboxy x rhodamine analogs |
| 05/30/2013 | WO2013077319A1 Method for removing impurities |
| 05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
| 05/28/2013 | CA2508990C Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/23/2013 | US20130131045 Benzazepine compound |
| 05/23/2013 | US20130129811 Cationic lipid |
| 05/22/2013 | CN103119021A Anti-inflammatory agents |
| 05/22/2013 | CN103113302A Method for preparing iminostilbene |
| 05/16/2013 | WO2013070107A1 5h-dibenzo[b,e][1,4]diazepine derivatives and use thereof |
| 05/16/2013 | US20130123490 Process for the asymmetric transfer hydrogenation of ketones |
| 05/16/2013 | US20130121978 Chemical and biological agents for the control of molluscs |
| 05/15/2013 | CN102432032B Nanometer all-silicon molecular sieve and its preparation method and use |
| 05/15/2013 | CN102311386B Caprolactam suspension filtering and washing method |
| 05/15/2013 | CN102260213B Method for preparing tolvaptan |
| 05/15/2013 | CN102219741B Process for preparing benzazepine compounds or salts thereof |
| 05/10/2013 | WO2013064427A1 A process for making crystalline delta-form of ivabradine hydrochloride |
| 05/10/2013 | WO2013064307A1 Ivabradine hydrochloride form iv |
| 05/10/2013 | WO2013040471A3 Noribogaine salt ansolvates |
| 05/10/2013 | CA2854549A1 Ivabradine hydrochloride form iv |
| 05/09/2013 | US20130116398 Processes for producing caprolactam and derivatives thereof from fermentation broths containing diammonium adipate, monoammonium adipate and/or adipic acid |
| 05/09/2013 | US20130116227 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 05/08/2013 | EP2589594A1 Ivabradine hydrochloride Form IV |
| 05/08/2013 | CN103097356A Preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2-{2-[methyl-(sulphamoyl)-amino]-ethoxy}-ethyl)-carbamoyl]-7H-indolo-[2,1-a]-[2]-benzazepine-10-carboxylic acid |
| 05/08/2013 | CN103086969A Synthesis method of iminostilbene carbonyl chloride |
| 05/08/2013 | CN103086968A Method for refining caprolactam through fixed-bed hydrogenation |
| 05/07/2013 | US8435979 Use of imipramine blue and analogs thereof in treating cancers |
| 05/02/2013 | US20130109672 Activators of human pyruvate kinase |
| 05/01/2013 | EP2585438A1 PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2-{2-[METHYL-(SULPHAMOYL)-AMINO]-ETHOXY}-ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID |
| 05/01/2013 | EP2585431A1 Metal free bleaching composition |
| 05/01/2013 | CN103080090A Anti-inflammatory agents |
| 05/01/2013 | CN103073498A Novel preparation method for (R)-Alpha-amino-e-caprolactam |
| 05/01/2013 | CN103073497A Method and device for preparing caprolactam through cyclohexanone oxime rearrangement reaction |
| 05/01/2013 | CN103073472A Preparation method of 2-trifluoromethyl-1-carbobenzoxy-1-aza-cyclane |
| 05/01/2013 | CN103073372A Method for synthesizing amine compound catalyzed by functionalized ionic liquid |
| 04/25/2013 | WO2013058691A1 Method for inhibition of deubiquitinating activity |
| 04/25/2013 | WO2013058121A1 PRODUCTION METHOD FOR ε-CAPROLACTAM |
| 04/25/2013 | WO2013057320A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | US20130102774 Thionation process and a thionating agent |
| 04/25/2013 | CA2852518A1 Method for inhibition of deubiquitinating activity |
| 04/25/2013 | CA2852355A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/24/2013 | EP2582686A1 Processes for the production of hydrogenated products and derivatives thereof |
| 04/24/2013 | EP2582679A1 Processes for producing caprolactam and derivatives thereof from fermentation broths containing diammonium adipate, monoammonium adipate and/or adipic acid |
| 04/24/2013 | EP2582678A1 Processes for producing caprolactam and derivatives thereof from fermentation broths containing diammonium adipate or monoammonium adipate |
| 04/24/2013 | EP2582677A1 Processes for the production of hydrogenated products and derivatives thereof |
| 04/24/2013 | CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 04/24/2013 | CN102127018B Method for refining lappaconitine hydrobromide |
| 04/24/2013 | CN101550085B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 04/23/2013 | CA2548276C Keto lactam compounds and use thereof |
| 04/18/2013 | WO2013053377A1 High temperature lactam neutralisation |
| 04/18/2013 | US20130096105 ArylSulfonamide Based Matrix Metalloprotease Inhibitors |
| 04/17/2013 | EP2580197A1 Anti-inflammatory agents |
| 04/17/2013 | EP2580196A1 Anti-inflammatory agents |
| 04/17/2013 | EP2579860A2 Ivabradine-containing pharmaceutical composition with modified release |
| 04/17/2013 | CN202881141U Caprolactam oligomer separating and conveying system |
| 04/17/2013 | CN202876580U Caprolactam exhaust gas/dust recovery system |
| 04/17/2013 | CN103044328A Synthesis of novel rubber vulcanizer 1, 1'-caprolactamdisulfide |
| 04/17/2013 | CN101628872B New method for preparing functionalised benzocyclobutenes and its application in the synthesis of ivabradine and its addition salts |
| 04/16/2013 | US8420631 Serotonin receptor antagonist; therapy for obesity, antidepressants, obsessive-compulsive disorders |
| 04/10/2013 | CN102336708B Method and device for producing caprolactam through rearrangement of cyclohexanone oxime |
| 04/10/2013 | CN101168525B Method for preparing caprolactam |
| 04/09/2013 | US8415468 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 04/04/2013 | US20130085255 Process for Preparing Caprolactam and Polyamides Therefrom |
| 04/03/2013 | CN103012269A Novel ivabradine hydrochloride crystal form C and preparation method thereof |
| 04/03/2013 | CN103012268A Novel preparation method for ivabradine |
| 04/03/2013 | CN103012267A Novel crystalline object of benazepril hydrochloride and preparation method of crystalline object |